PTR [PETROCHINA CO] 6-K: PetroChina 2014 ANNUAL REPORT P E T R

[PetroChina 2014 ANNUAL REPORT P E T R O C H I N A C O M P A N Y L I M I T E D PetroChina 2014 ANNUAL REPORT P E T R O C H I N A C O M P A N Y L I M I T E D PetroChina PetroChina CONTENTS 002] [99.1 Announcement dated April 15, 2015 relating to the Company’s annual report. PetroChina Company Limited Dated: April 16, 2015 Wu Enlai Company Secretary 6-K 1 d909754d6k.htm FORM 6-K]

By | 2016-03-20T07:09:36+00:00 April 16th, 2015|Categories: Chinese Stocks, PTR, Webplus ver|Tags: , , , , , |0 Comments

JKS [JinkoSolar] 20-F: TABLE OF CONTENTS Page PART I 3

[TABLE OF CONTENTS Page PART I 3] [JINKOSOLAR HOLDING CO., LTD. 2014 EQUITY INCENTIVE PLAN 1. Purpose of the Plan The purpose of the Plan is to aid the Company and its Affiliates in recruiting and retaining key employees, directors or consultants of outstanding ability and to motivate such employees, directors or consultants to exert their best efforts on behalf of the Company and its Affiliates by] [Subscription Agreements Schedule The subscription agreements listed below are entered into between JinkoSolar WWG Investment Co., Ltd., JinkoSolar Power Engineering Group Limited, JinkoSolar Holding Co., Ltd., Jiangxi Jinko Solar Engineering Co., Ltd. and Jinko Power Co., Ltd. (the “JinkoSolar Entities”) and each of the preferred shareholders of our solar power generation subsidiary, JinkoSolar Power Engineering Group Limited, individually for the] [Subsidiaries Date of Incorporation Place of Incorporation Percentage of Ownership JinkoSolar Technology Limited November 10, 2006 Hong Kong 100% Jinko Solar Co., Ltd. December 13, 2006 PRC 100% Zhejiang Jinko Solar Co., Ltd. June 30, 2009 PRC 100% JinkoSolar International Limited November 25, 2009 Hong Kong 100% Jinko Solar Import and Export Co., Ltd. December 24, 2009 PRC 100% JinkoSolar] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER SARBANES-OXLEY ACT OF 2002 I, Kangping Chen, certify that: 1. I have reviewed this annual report on Form 20-F of JinkoSolar Holding Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [CERTIFICATION OF CHIEF FINANCIAL OFFICER SARBANES-OXLEY ACT OF 2002 I, Haiyun (Charlie) Cao, certify that: 1. I have reviewed this annual report on Form 20-F of JinkoSolar Holding Co., Ltd. ; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Kangping Chen Chief Executive Officer] [2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Haiyun (Charlie) Cao Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form PricewaterhouseCoopers Zhong Tian LLP Shanghai, the People's Republic of China April 16, 2015]

By | 2016-03-27T06:32:38+00:00 April 16th, 2015|Categories: Chinese Stocks, JKS, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: Cooperation Agreement on Transfer of Source Plasma and

[Cooperation Agreement on Transfer of Source Plasma and Plasma Ingredients I+II+III Sediments for Producing Blood Products This Agreement is entered into in the city of Beijing on September 30, 2014 by and between: Party A (Supplier): Xinjiang Deyuan Bioengineering Co., Ltd. Party B (Receiver): Guizhou Taibang Biological Products Co., Ltd. WHEREAS: PRC 1. Both parties are established in good standing] [Supplemental Agreement to Cooperation Agreement on Transfer of Source Plasma and Plasma Ingredients I+II+III Sediments for Producing Blood Products This Supplemental Agreement is entered into on April 16, 2015 by and between: Party A (Supplier): Xinjiang Deyuan Bioengineering Co., Ltd; Party B (Receiver): Guizhou Taibang Biological Products Co., Ltd Any term not otherwise defined herein shall have the meaning ascribed] [FOR RELEASE April 16, 2015 China Biologic Receives Approval to Purchase Raw Materials BEIJING, China – April 16, 2015 – These raw materials are expected to be delivered during the second quarter of 2015, and the final purchase volume is contingent upon the Company's quality inspection of these raw materials. The Company expects that the final products made from such] []

LFC [CHINA LIFE INSURANCE CO] 6-K: (A joint stock limited company incorporated in the

[(A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME CIRC Reference is made to the Company’s announcement dated 27 August 2004. The accumulated premium income of the Company for the period from 1 January 2015 to 31 March 2015 was about RMB153.4 billion. The figure is to] [Description 99.1 Announcement, dated April 16, 2015 China Life Insurance Company Limited]

By | 2016-03-19T20:46:25+00:00 April 16th, 2015|Categories: Chinese Stocks, LFC, Webplus ver|Tags: , , , , , |0 Comments

DATE [JIAYUAN.COM INTERNATIONAL] 20-F: FORM 20-F (Mark One) o OR x OR

[FORM 20-F (Mark One) o OR x OR o OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . For the transition period from to Jiayuan.com International Ltd. Not Applicable Cayman Islands (Jurisdiction of incorporation or organization) 15/F, Anhua Development Building] [As of March 31, 2015 Wholly-Owned Subsidiaries 1. Harper Capital Inc., a British Virgin Islands company 2. Jiayuan Hong Kong Corporation Limited, a Hong Kong company 3. Miyuan (Shanghai) Information Technology Co., Ltd., a PRC company 4. Beijing Miyuan Information Technology Co., Ltd., a PRC company 5. Shanghai Huaqianshu Information Technology Co., Ltd., a PRC company 6. Beijing Huaqianshu Information] [Certification by the Chief Executive Officer I, Linguang Wu, certify that: 1. I have reviewed this annual report on Form 20-F of Jiayuan.com International Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Financial Officer I, Shang-Hsiu Koo, certify that: 1. I have reviewed this annual report on Form 20-F of Jiayuan.com International Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Executive Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Linguang Wu Chief Executive Officer EX-13.1 5 a15-2912_1ex13d1.htm SECTION 906 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER] [Certification by the Chief Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Shang-Hsiu Koo Chief Financial Officer EX-13.2 6 a15-2912_1ex13d2.htm SECTION 906 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (Nos. 333-177877 and 333-184079) of Jiayuan.com International Ltd., of our report dated April 16, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. Beijing, the People’s] [April 16, 2015 Jiayuan.com International Ltd. 15/F, Anhua Development Building No. 35 Anding Road Chaoyang District, Beijing 100029 People’s Republic of China Ladies and Gentlemen: SEC Annual Report Yours faithfully, Zhong Lun Law Firm EX-15.2 8 a15-2912_1ex15d2.htm CONSENT OF ZHONG LUN LAW FIRM] [Consent of iResearch Consulting Group April 2, 2015 Jiayuan.com International Ltd. 15/F Anhua Development Building No. 35 Anding Road Chaoyang District, Beijing The People’s Republic of China Ladies and Gentlemen: iResearch Consulting Group hereby consents to references to its name in the annual report on Form 20-F of Jiayuan.com International Ltd. (the “Company”) for the fiscal year ended December 31,] [Our ref JUH/660390-000001/8046428v2 Direct tel +852 3690-7431 E-mail juno.huang@maplesandcalder.com Jiayuan.com International Ltd. 15 th Floor, Anhua Development Building No.35 An Ding Road Chao Yang District Beijing, China 16 April 2015 Dear Sir Jiayuan.com International Ltd. (the “Company”) Company Form 20-F We have acted as legal advisers as to the laws of the Cayman Islands to Jiayuan.com International Ltd. an exempted]

CYD [CHINA YUCHAI INTERNATIONAL] 20-F: CHINA YUCHAI INTERNATIONAL LIMITED Page Certain Definitions and

[CHINA YUCHAI INTERNATIONAL LIMITED Page Certain Definitions and Supplemental Information 2 2 Part I Item 1. Identity of Directors, Senior Management and Advisers 4 Item 2. Offer Statistics and Expected Timetable 4 Item 3. Key Information 4 Item 4. Information on the Company 22 Item 4A. Unresolved Staff Comments 38 Item 5. Operating and Financial Review and Prospects 38 Item] [The particulars of the Company’s subsidiaries as at December 31, 2014 are set forth below: Attributable equity interests Name of company Jurisdiction Direct Indirect Guangxi Yuchai Machinery Company Limited People’s Republic of — 76.4 % Guangxi Yuchai Accessories Manufacturing Company Limited PRC — 76.4 % Guangxi Yulin Yuchai Accessories Manufacturing Company Limited PRC — 74.2 % Guangxi Yuchai Machinery Monopoly] [TO SECTION 302 OF THE SARBANES-OXLEY ACT I, Hoh Weng Ming, certify that: 1. I have reviewed this annual report on Form 20-F of China Yuchai International Limited (the “Company”); 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [TO SECTION 906 OF THE SARBANES-OXLEY ACT (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. TO SECTION 906 OF THE SARBANES-OXLEY ACT (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [Consent of Independent Registered Public Accountant Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-197287) pertaining to the Equity Incentive Plan of China Yuchai International Limited of our reports dated April 15, 2015, with respect to the consolidated financial statements of China Yuchai International Limited and the effectiveness of internal control over financial]

By | 2016-03-28T12:30:47+00:00 April 15th, 2015|Categories: Chinese Stocks, CYD, Webplus ver|Tags: , , , , , |0 Comments

MPEL [Melco Crown Entertainment] 6-K: Melco Crown Entertainment ANNUAL REPORT 2014 MELCO CROWN

[Melco Crown Entertainment ANNUAL REPORT 2014 MELCO CROWN ENTERTAINMENT LIMITED and NASDAQ (Symbol: MPEL) (Incorporated in the Cayman Islands with limited liability) THE HOUSE of DANCING WATER CITY OF DREAMS A premier leisure and entertainment destination in Macau that offers the ultimate in innovative, highly contemporary and world-class leisure experiences that appeal to the rapidly evolving demands of the Asian-leisure] [Form 6–K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED Geoffrey Davis, CFA]

By | 2016-03-30T01:13:18+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: Biostar Pharmaceuticals, Inc. Announces Its Full Year and

[Biostar Pharmaceuticals, Inc. Announces Its Full Year and Fourth Quarter 2014 Financial Results Full Year 2014 Financial Highlights · Net sales increased by $8.7 million, or 16.5%, year over year, from $52.7 million in 2013 to $61.4 million in 2014. · Gross profit grew by approximately 17.9% from $25.7 million in 2013 to $30.3 million in 2014. · Cash and] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): April 15, 2015 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By | 2016-03-28T18:03:29+00:00 April 15th, 2015|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 10-K: FORM 10-K (Mark One) x December 31, 2014

[FORM 10-K (Mark One) x December 31, 2014 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [Biostar Pharmaceuticals, Inc. List of subsidiaries As of December 31, 2014 Name Place of incorporation Shaanxi Biostar Biotech Ltd People’s Republic of China Shaanxi Aoxing Pharmaceutical Co. Ltd. People’s Republic of China Shaanxi Weinan Haren Pharmaceuticals, Ltd. People’s Republic of China EX-21 2 ex21.htm EX-21] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Clement C. W. Chan & Co. Certified Public Accountants Hong Kong April 15, 2015 EX-23.1 3 ex23-1.htm EX-23.1] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Clement C. W. Chan & Co. Certified Public Accountants Hong Kong April 15, 2015 EX-23.2 4 ex23-2.htm EX-23.2] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 15, 2015 EX-23.3 5 ex23-3.htm EX-23.3] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 15, 2015 EX-23.4 6 ex23-4.htm EX-23.4] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 15, 2015 Ronghua Wang Chief Executive Officer EX-32.1 9 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 15, 2015 Qinghua Liu Interim Chief Financial Officer EX-32.2 10 ex32-2.htm EX-32.2]

By | 2016-03-28T18:07:39+00:00 April 15th, 2015|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

GOMO [Sungy Mobile] SC 13D: AGREEMENT OF JOINT FILING Dated: April 15, 2015

[AGREEMENT OF JOINT FILING Dated: April 15, 2015 Yuqiang Deng Yuqiang Deng Zhi Zhu Zhi Zhu Freedom First Holdings Limited Yuqiang Deng Director Credit Suisse Trust Limited Camille Le Conte Geoffrey Le Poidevin Authorised Signatory DENG Holdings Limited] [Proposal Letter April 13, 2015 The Board of Directors SUNGY MOBILE LIMITED (the “Company”) Floor 17, Tower A, China International Center No. 33 Zhongshan 3rd Road Yuexiu District, Guangzhou 510055 People’s Republic of China Dear Sirs and Madams: We, Yuqiang Deng and Zhi Zhu (collectively, “we” or “us”) are pleased to submit this preliminary non-binding proposal to acquire all of] [CUSIP No. 86737M 100 1. Name of Reporting Person. Yuqiang Deng 2. Check the Appropriate Box if a Member of a Group (See Instructions) x ¨ (a) 3. SEC Use Only 4. Source of Funds (See Instructions) OO – See Item 3 5. ¨ 6. Citizenship or Place of Organization People’s Republic of China]

By | 2016-03-18T18:28:44+00:00 April 15th, 2015|Categories: Chinese Stocks, GOMO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar